Abstract
Background
The Q.Clear algorithm is a fully convergent iterative image reconstruction technique. We hypothesize that different PET/CT scanners with distinct crystal properties will require different optimal settings for the Q.Clear algorithm. Many studies have investigated the improvement of the Q.Clear reconstruction algorithm on PET/CT scanner with LYSO crystals and SiPM detectors. We propose an optimum penalization factor (β) for the detection of rectal cancer and its metastases using a BGO-based detector PET/CT system which obtained via accurate and comprehensive phantom and clinical studies.
Methods
18F-FDG PET-CT scans were acquired from NEMA phantom with lesion-to-background ratio (LBR) of 2:1, 4:1, 8:1, and 15 patients with rectal cancer. Clinical lesions were classified into two size groups. OSEM and Q.Clear (β value of 100–500) reconstruction was applied. In Q.Clear, background variability (BV), contrast recovery (CR), signal-to-noise ratio (SNR), SUVmax, and signal-to-background ratio (SBR) were evaluated and compared to OSEM.
Results
OSEM had 11.5–18.6% higher BV than Q.Clear using β value of 500. Conversely, RC from OSEM to Q.Clear using β value of 500 decreased by 3.3–7.7% for a sphere with a diameter of 10 mm and 2.5–5.1% for a sphere with a diameter of 37 mm. Furthermore, the increment of contrast using a β value of 500 was 5.2–8.1% in the smallest spheres compared to OSEM. When the β value was increased from 100 to 500, the SNR increased by 49.1% and 30.8% in the smallest and largest spheres at LBR 2:1, respectively. At LBR of 8:1, the relative difference of SNR between β value of 100 and 500 was 43.7% and 44.0% in the smallest and largest spheres, respectively. In the clinical study, as β increased from 100 to 500, the SUVmax decreased by 47.7% in small and 31.1% in large lesions. OSEM demonstrated the least SUVmax, SBR, and contrast. The decrement of SBR and contrast using OSEM were 13.6% and 12.9% in small and 4.2% and 3.4%, respectively, in large lesions.
Conclusions
Implementing Q.Clear enhances quantitative accuracies through a fully convergent voxel-based image approach, employing a penalization factor. In the BGO-based scanner, the optimal β value for small lesions ranges from 200 for LBR 2:1 to 300 for LBR 8:1. For large lesions, the optimal β value is between 400 for LBR 2:1 and 500 for LBR 8:1. We recommended β value of 300 for small lesions and β value of 500 for large lesions in clinical study.
Keywords: Bayesian method, 18F-FDG, PET-CT, Image reconstruction
Introduction
The combination of positron emission tomography (PET) with computed tomography (CT) is commonly employed as a powerful imaging tool in the clinical assessment of oncological issues [1]. There is a growing desire to enhance the spatial resolution in PET scanners to achieve better detectability, particularly for small lesions [2]. The precise determination of radiopharmaceutical's standardized uptake value (SUV) in lesions and body regions is influenced by various factors, among which the reconstruction method plays a pivotal role [3]. Analytical and iterative reconstruction stands as the two primary methods used for image reconstruction [4]. Analytical reconstruction techniques offer a direct mathematical approach to image generation, encompassing filtered back-projection and the Fourier transformation method [5, 6]. Iterative methods involve a more intricate mathematical solution that requires multiple iterations to yield an image. These iterative algorithms enhance image quality by enabling more precise modeling of the data acquisition process [7]. The ordered subset expectation maximization (OSEM) method stands as the most widely utilized iterative reconstruction method in PET imaging [8]. In OSEM, the image noise escalates as the number of iterations increases. To manage the noise, the algorithm is halted before the noise becomes excessive (typically 2–4 iterations) and post-filtered [9, 10]. Due to the limitation on the number of iterations used, each image voxel is incompletely converged; hence, quantitative parameters are not estimated correctly [11, 12].
The block sequential regularized expectation maximization (BSREM) is a Bayesian penalized likelihood (BPL) reconstruction algorithm, marketed under the name Q.Clear (GE Healthcare, Milwaukee, WI, USA [13]. Like other algorithms, Q.Clear incorporates point spread function modeling and, additionally, a relative difference penalty (RDP), which considers the relative difference between neighboring voxels to prevent excessive smoothing along significant edges [14, 15]. The influence of RDP is regulated by a user-defined parameter referred to as the penalization factor (β value), which governs the overall degree of noise suppression in Q.Clear, thereby allowing for numerous iterations without a corresponding increase in noise [16]. A higher number of iterations facilitates complete convergence for each individual voxel, enabling accurate estimation of quantitative parameters. It is worth noting that an improper optimization of the beta factor leads to poor image quality and diminished lesion detection [17].
Lutetium oxyorthosilicate (LSO) and lutetium yttrium oxyorthosilicate (LYSO) detectors are currently favored in commercial time of flight (TOF) systems due to their quicker decay times and shorter coincidence timing windows. Bismuth germanium oxide (BGO) detectors possess a broader coincidence window, rendering the incorporation of TOF technology into a PET system utilizing BGO crystals unfeasible. The BGO timing resolution is lower than that for LYSO and LSO, due to its longer decay time and lower light output. This deficiency contributes to higher scatter and elevated noise levels within the BGO scanner. Despite this, BGO crystals still offer specific advantages, such as a higher effective atomic number that results in increased detection efficiency, lower intrinsic radiation, and reduced production costs. However, their utilization necessitates reconstruction enhancement procedures [18]. A PET system's sensitivity is pivotal in achieving adequate counting statistics for a favorable signal-to-noise ratio during image reconstruction [19]. Our study's hypothesis is that various scanners, distinguished by different attributes most notably crystal type, coincidence timing window, and FOV will yield disparate images. Consequently, a comprehensive exploration of each scanner becomes imperative to evaluate the image quality and quantification performance of the Q.Clear reconstruction algorithm. A plethora of prior research has investigated the efficacy of Q.Clear in enhancing 18F-FDG PET imaging on scanners using LYSO crystals and integrating TOF technology [20–23].
For instance, Lindström et al. analyzed data from a NEMA image quality phantom and clinical whole-body scans, including 68Ga-DOTATOC (n = 13), 18F-fluoride (n = 10), and 11C-acetate (n = 13). The data were acquired using a GE Discovery MI equipped with LYSO crystals, and reconstructed images were generated through both OSEM and Q.Clear methods, using β values of 133, 267, 400, and 533 (both algorithms incorporating TOF and PSF techniques). In tracer-specific ranges of β values, Q.Clear reconstruction yielded higher SNR (a minimum of 25%) and SBR (a maximum of 23%) compared to conventional OSEM reconstruction. Comparable levels of SNR, SBR, and noise could be achieved with BSREM in shorter acquisition times or with lower administered dosages, contrary to what OSEM could achieve[22].
Ahn et al. examined 25 patients and NEMA, anthropomorphic, and oval phantoms scanned with LYSO crystals on a GE Discovery PET/CT 690 scanner. Images were reconstructed with Q.Clear with a β value of 350 and OSEM. Their findings indicated enhanced accuracy in lesion quantitation for Q.Clear in comparison with OSEM, with a notable improvement observed in regions with low uptake, such as the lungs [21]. Our study was conducted using a non-time of flight discovery IQ PET/CT scanner equipped with BGO crystals and a 26-cm axial field of view (FOV).
To the best of our knowledge, Q.Clear's performance using different β values in terms of lesion size at various activity levels has not been extensively undertaken. Our previous research exclusively conducted a phantom study at only a lesion-to-background ratio of 4 (LBR 4:1) to evaluate Q.Clear in 68Ga-PSMA PET-CT examinations. We concluded that at LBR 4:1, Q.Clear with a β value of 400 is most effective for reconstructing small lesions, while larger lesions in the phantom benefit from β values of 600 [24]. Chen et al. analyzed data from a NEMA/IEC image quality phantom with a concentration ratio of 4:1 for 18F-FDG solution in spheres. The data were acquired using a 3-ring DMI scanner and were reconstructed using Q.Clear with β values ranging from 100 to 500 at 100-point intervals, in contrast to OSEM. The target-to-background ratio (TBR) and contrast noise ratio (CNR) exhibited an increase corresponding to the higher beta value, whereas the noise demonstrated an inverse trend, except for the smallest sphere (10 mm diameter). For the smallest hot sphere, the TBR reached a plateau when the beta value reached 300, while the CNR gradually declined thereafter [25]. This study aimed to thoroughly investigate Q.Clear reconstruction by conducting an extensive analysis utilizing a combination of phantom and clinical studies. In the context of 18F-FDG radiopharmaceutical studies, the lesion-to-background ratio emerges as a crucial parameter for consideration. We incorporated three different lesion-to-background ratios in our phantom study, facilitating the evaluation of diverse lesion sizes while simulating various focal point uptakes.
Discovery IQ PET/CT scanners, which utilize BGO crystals, have gained worldwide recognition and acceptance among clinicians. The next generation of Discovery IQ has been meticulously engineered and designed to function as a scalable, high-performance diagnostic system capable of delivering exceptional image quality while employing a reduced dose. However, due to the widespread adoption of BGO crystals, specialized studies pertaining to these crystals are imperative. Our study evaluated the influence of distinct penalty functions within the Q.Clear algorithm on 18F-FDG PET-CT images using a non-time-of-flight PET/CT system based on BGO crystals. The quantitative evaluation encompassed different penalization factors (β) for both phantom and clinical data across various LBRs.
Methods
Phantom study
The images were acquired using our department's GE Discovery IQ PET-CT system (GE Healthcare, USA). The scanner features five detector rings with 36 detector units per ring. Each detector is comprised of 6.3 × 6.3 × 30 mm BGO crystals. The scanner has a 70-cm trans-axial field of view (FOV) and a 26-cm axial FOV. It includes a 16-slice CT scanner. The PET images were reconstructed using Q.Clear and OSEM + PSF. According to previous studies, for oncology whole-body 18F-FDG scans, the β value is typically set within the range of 400–450 [20, 23, 26, 27]. The optimal number of iterations for full convergence, as suggested by the manufacturer, is 25. Additionally, the manufacturer recommends the OSEM algorithm with 4 iterations, 24 subsets, and 4.8 mm Gaussian post-filtering for standard clinical image reconstruction using 18F-FDG. Thus, in our study, Q.Clear reconstruction employed 25 iterations and β values ranging from 100 to 500 in intervals of 100. OSEM + PSF (routine protocol), referred to as OSEM in this paper, was applied according to the manufacturer's suggestion [28].
A National Electrical Manufacturers Association (NEMA) image quality phantom with a total volume of 9780 ml and a height of 19.4 cm was utilized [29]. This phantom contains six spheres with diameters of 10, 13, 17, 22, 28, and 37 mm [30]. The spheres were filled with an 18F-FDG solution to achieve lesion-to-background ratios (LBR) of 2:1, 4:1, and 8:1. The background was filled with activity concentrations of 5.1, 4.9, and 5 KBq/ml of 18F-FDG, respectively. A lung insert at the center of the phantom with an LBR of 8:1 was incorporated to simulate human lung tissue. This insert was filled with water and Styrofoam.
According to NEMA phantom analysis standards, metrics such as maximum standard uptake value (), contrast recovery (CR), recovery coefficient (RC), background variability (BV), lung residual error (LE), contrast, and signal-to-noise ratio (SNR) were measured. Each image was analyzed using PMOD software (version 3.8, developed by PMOD-Technologies LLC, Zurich, Switzerland) [16, 31, 32]. For image assessment in the PMOD, the slice traversing the central region of the spheres is identified. In this slice and two slices before and after, 12 ROIs with a diameter of 10 mm are delineated in each slice within the background area. Therefore, a total of 60 ROIs are considered in the phantom's background region. The ROIs are drawn, ensuring their distance from both the spheres and the phantom edge is no less than 15 mm (Fig. 1). To incorporate spherical regions, the volume of interest (VOI) was positioned within the central slice of spheres, with each sphere having a diameter proportionate to its individual sphere diameter.
CR was defined as the following:
1 |
where is the mean count in hot spheres, is the mean count in the background, and represents the target ratio of the hot activity. RC is defined as the ratio of measured activity to the true activity of each insert. The coefficient of variation (COV) is used as a metric for describing BV in the image [33]. BV is calculated as the ratio of SD to the mean activity in 60 background regions of interest (ROIs) [26]. The LE is determined as the ratio of mean activity in lung insert to mean activity in background ROIs.
Contrast is determined as the mean voxel value in each sphere divided by the mean voxel value of the background (BG) ROIs, and SNR is the ratio of the mean voxel count of each sphere to the SD of BG ROIs.
To compare the effects of different β values, the relative changes in each assessment parameter were examined at consistent intervals of β values. For this purpose, the relative difference between reconstruction a and reconstruction b was calculated as:
2 |
Clinical study
We assessed the three-dimensional whole-body 18F-FDG PET-CT scans of 15 patients (11 men and 4 women) diagnosed with rectal cancer. The patients, with a weight range of 45–100 kg, a median height of 160 cm, and a median age of 60 years, were intravenously administrated an activity concentration of 3.5–5 MBq of 18F-FDG per kilogram of body weight. All patients fasted for six hours before the injection, and the uptake time range was 60 ± 3.0 min. Images were captured with an acquisition time of 3 min per bed position (min/bp).
For the purpose of clinical image assessment, all lesions were identified by two nuclear medicine specialists and were subsequently enclosed with a volume of interest (VOI) to encompass them entirely. In the clinical data, we examined primary tumor in rectum and rectal cancer metastases spread throughout the lung and pelvic (15 primary rectal tumors, 12 lung metastases, and 18 pelvic metastatic lesions). These 45 lesions were assessed and categorized into two size groups: 27 small lesions (diameter ⩽ 10 mm) and 18 large lesions (diameter > 10 mm). Table 1 illustrates the mean activity of individual lesions alongside their respective tumor types, categorized into two size groups. For the quantitative analysis, nine ROIs with a diameter of 30 mm were positioned in the three largest slices of the right lobe of the liver [34]. The liver noise was calculated as the ratio of the standard deviation to the mean activity of ROIs in the liver. SNR was defined as the lesion divided by liver noise, and signal-to-background ratio (SBR) was calculated as the lesion divided by of the liver.
Table 1.
Small lesions (diameter ⩽ 10 mm) | |||||||
---|---|---|---|---|---|---|---|
Lesion | β value = 100 | β value = 200 | β value = 300 | β value = 400 | β value = 500 | OSEM | Tumor type |
1 | 14.62 | 14.05 | 13.5 | 13.05 | 12.63 | 10.94 | Primary rectal tumor |
2 | 33.66 | 32.93 | 32.29 | 31.7 | 31.16 | 28.24 | Primary rectal tumor |
3 | 26.59 | 25.73 | 24.97 | 24.24 | 23.55 | 19.91 | Primary rectal tumor |
4 | 33.85 | 32.94 | 32.16 | 31.41 | 30.71 | 26.34 | Primary rectal tumor |
5 | 33.2 | 30.52 | 28.26 | 26.26 | 24.49 | 19.87 | Primary rectal tumor |
6 | 19.71 | 19.17 | 18.65 | 18.16 | 17.7 | 15.57 | Primary rectal tumor |
7 | 16.6 | 16 | 15.4 | 14.82 | 14.29 | 14.26 | Primary rectal tumor |
8 | 36.4 | 35.88 | 35.36 | 34.83 | 34.31 | 30.98 | Lung metastasis |
9 | 26.29 | 25.62 | 24.99 | 24.37 | 23.78 | 22.29 | Lung metastasis |
10 | 11.35 | 10.96 | 11.71 | 10.57 | 10.21 | 9.11 | Lung metastasis |
11 | 12.05 | 11.59 | 12.48 | 11.14 | 10.74 | 9.72 | Lung metastasis |
12 | 13.61 | 12.59 | 14.88 | 11.75 | 11.04 | 9.18 | Lung metastasis |
13 | 18.59 | 16.93 | 20.68 | 15.62 | 14.58 | 12.85 | Lung metastasis |
14 | 17.56 | 17.35 | 17.12 | 16.86 | 16.59 | 15.5 | Lung metastasis |
15 | 17.37 | 16.74 | 16.21 | 15.74 | 15.34 | 14.01 | Lung metastasis |
16 | 12.27 | 12.01 | 11.74 | 11.49 | 11.22 | 10.29 | Pelvic metastasis |
17 | 14.054 | 13.82 | 13.59 | 13.37 | 13.14 | 12.29 | Pelvic metastasis |
18 | 19.86 | 17.69 | 15.8 | 14.27 | 13.017 | 10.04 | Pelvic metastasis |
19 | 18.4 | 17.71 | 16.32 | 15.78 | 15.25 | 13.16 | Pelvic metastasis |
20 | 13.92 | 13.62 | 12.65 | 12.24 | 11.88 | 11.02 | Pelvic metastasis |
21 | 21.52 | 18.42 | 17.74 | 17.39 | 17.01 | 16.33 | Pelvic metastasis |
22 | 23.08 | 21.07 | 19.75 | 18.78 | 18.43 | 17.55 | Pelvic metastasis |
23 | 25.32 | 22.34 | 21.27 | 20.73 | 20.27 | 18.67 | Pelvic metastasis |
24 | 19.39 | 16.78 | 15.43 | 14.25 | 13.2 | 11.42 | Pelvic metastasis |
25 | 14.92 | 14.65 | 14.25 | 13.79 | 13.46 | 12.31 | Pelvic metastasis |
26 | 17.05 | 14.1 | 12.59 | 11.68 | 10.87 | 11.22 | Pelvic metastasis |
27 | 40.26 | 38.34 | 36.77 | 35.48 | 34.22 | 27.96 | Pelvic metastasis |
Large lesions (diameter > 10 mm) | |||||||
---|---|---|---|---|---|---|---|
Lesion | β value = 100 | β value = 200 | β value = 300 | β value = 400 | β value = 500 | OSEM | Tumor type |
1 | 30.71 | 30.27 | 29.84 | 29.45 | 29.07 | 29.59 | Primary rectal tumor |
2 | 21.92 | 21.4 | 21.02 | 20.72 | 20.46 | 20.78 | Primary rectal tumor |
3 | 34.89 | 34.08 | 33.35 | 32.67 | 32.04 | 31.56 | Primary rectal tumor |
4 | 30.22 | 29.79 | 29.42 | 29.1 | 28.81 | 27.5 | Primary rectal tumor |
5 | 27.51 | 27.29 | 27.06 | 26.86 | 26.66 | 25.77 | Primary rectal tumor |
6 | 8.99 | 8.87 | 8.78 | 8.67 | 8.51 | 7.34 | Primary rectal tumor |
7 | 9.06 | 8.94 | 8.84 | 8.74 | 8.62 | 8.28 | Primary rectal tumor |
8 | 8.22 | 7.91 | 7.28 | 6.98 | 6.88 | 6.23 | Primary rectal tumor |
9 | 17.36 | 17.83 | 17.3 | 17.27 | 17.24 | 16.62 | Lung metastasis |
10 | 18.05 | 18.27 | 17.8 | 17.55 | 17.31 | 16.51 | Lung metastasis |
11 | 43.14 | 42.06 | 41.41 | 40.99 | 40.7 | 38.29 | Lung metastasis |
12 | 22.7 | 20.23 | 19.35 | 18.65 | 18.06 | 19.85 | Lung metastasis |
13 | 15.79 | 14.29 | 13.35 | 12.65 | 12.12 | 14.16 | Pelvic metastasis |
14 | 32.43 | 28.86 | 26.9 | 26.17 | 25.44 | 26.89 | Pelvic metastasis |
15 | 26.21 | 23.14 | 21.69 | 20.67 | 19.87 | 19.5 | Pelvic metastasis |
16 | 36.17 | 35.03 | 34.08 | 33.26 | 32.44 | 30.64 | Pelvic metastasis |
17 | 10.06 | 8.7 | 8.042 | 7.6 | 7.26 | 6.31 | Pelvic metastasis |
18 | 16.39 | 12.39 | 10.53 | 9.58 | 8.92 | 8.55 | Pelvic metastasis |
Statistical analysis
We employed paired Student t test in both our phantom and clinical studies. We conducted the t test individually for each evaluation parameter. This involved comparisons between two distinct reconstruction approaches, either comparing results derived from different β values or contrasting outcomes from a single β value with those from OSEM reconstruction. Statistical variances in image evaluation were assessed using the analysis of variances (ANOVA), followed by post hoc Bonferroni corrections to adjust comparisons among multiple reconstructions. P value < 0.05 was set as the significance level [35]. Statistical analyses were conducted using the SPSS software version 23.0 (IBM Corporation, Armonk, NY, USA).
Results
NEMA phantom
Figure 2 illustrates the results of BV and RC in phantom studies with LBRs of 2:1, 4:1, and 8:1. With Q.Clear reconstructions, BV increased as the β value decreased. The were − 39.7%, − 35.6%, and − 38.5%, and were − 11.2%, − 13.3%, and − 14.7% for LBRs of 2:1, 4:1, and 8:1, respectively. OSEM presented 11.5%, 18.6%, and 17.0% higher BV than . A decreasing β value escalated the RC. The percentage changes between OSEM and were − 3.3%, − 5.1%, and − 7.7% for the smallest sphere (10 mm) and − 2.5%, − 4.2%, and − 5.1% for the largest sphere (37 mm) at LBRs of 2:1, 4:1, and 8:1. Figure 3 displays NEMA phantom slices reconstructed with Q.Clear and OSEM for varying LBRs and β values. Elevated noise in compromised the image quality. Higher β values improved homogeneity for low LBRs, whereas lower β values were preferable for high LBRs compared to their low counterparts.
Figure 4 showcases the CR and contrast for various sphere sizes and LBRs in phantom studies. There was a negative correlation between β values and lesion CR. Q.Clear consistently demonstrated higher CR and contrast compared to OSEM across all sphere dimensions and LBRs. For instance, at LBR 2:1, OSEM's CR values were 19.1%, 10.3%, and 6.1% lower than for 10 mm, 22 mm, and 37 mm spheres, respectively. The relative contrast difference expanded with diminishing β values. At LBRs of 2:1, 4:1, and 8:1, OSEM had percentage disparities of − 8.1%, − 7.0%, and − 5.2%, compared to for the 10 mm sphere. Refer to Fig. 4 for more detailed results.
There was an inverse correlation between LE and β value. At LBR of 8:1, the LE values stood at 14.6 for and 28.4 for OSEM. The lowest SNR was observed for . The percentage SNR difference between and was 49.1% for the smallest sphere (10 mm) and 30.8% for the largest sphere (37 mm) at an LBR of 2:1. Increasing the LBR did yield a meaningful difference (p > 0.05) in SNR across different lesion sizes. At an LBR of 8:1 (according to Table 2), the percentage SNR difference between the and was 43.7% for the smallest sphere (10 mm) and 44.0% for the largest sphere (37 mm). For spheres sized 10 mm, 22 mm, and 37 mm, OSEM had 30.6%, 20.4%, and 18.8% reduced SNR than .
Table 2.
LBR | Lesion size | Relative difference of SNR(%) | |||||
---|---|---|---|---|---|---|---|
2:1 | 10 mm | 26.5 | 16 | 11.4 | 8.8 | 49.1 | − 4.9 |
22 mm | 24.9 | 12.8 | 6.9 | 3.9 | 42.8 | − 0.9 | |
37 mm | 18.3 | 8.4 | 4.7 | 2.9 | 30.8 | 1.2 | |
p | S | S | S | S | S | S | |
4:1 | 10 mm | 26.1 | 14.8 | 9.5 | 7.3 | 45.1 | − 10.2 |
22 mm | 24.6 | 12.2 | 6.8 | 6.9 | 40.5 | − 7.3 | |
37 mm | 21.7 | 10.6 | 6.4 | 4.7 | 37.4 | − 3.1 | |
p | S | S | S | NS | S | S | |
8:1 | 10 mm | 25.2 | 13.6 | 8.7 | 6 | 43.7 | − 30.6 |
22 mm | 24.2 | 13.5 | 8.3 | 5.6 | 40.7 | − 20.4 | |
37 mm | 22.1 | 12.5 | 8 | 5.4 | 44.0 | − 18.8 | |
p | S | S | S | NS | S | S | |
Relative difference of LE(%) | |||||||
8:1 | Lung insert | ||||||
− 5.3 | − 4.1 | − 3.8 | − 3.2 | − 13.1 | 54.5 | ||
p | S | S | NS | NS | S | S |
Additionally, the relative difference in lung residual error between OSEM and Q.Clear in the lung insert of the NEMA IEC phantom at the LBR of 8:1 is presented (Below). P values were deduced using a paired t test. ‘S’ denotes statistically significant differences (p value ≤ 0.05), whereas 'NS' indicates no significant variation (p value > 0.05).
Clinical study
Figure 5 showcases the coronal view of a patient with rectal cancer. It reveals that lower β values degrade image quality and the signal-to-noise ratio (SNR) due to amplified noise. Conversely, elevated β values enhance image clarity and SNR by proficiently diminishing noise. Figure 6 presents a quantitative analysis of 45 lesions across all reconstruction algorithms. It demonstrates that escalating β values precipitate a reduction in both and noise. The percentage difference in between and stood at − 47.7% for smaller lesions and − 33.1% for larger lesions. OSEM exhibited a reduced compared to all other reconstruction methods. Consequently, the percentage difference in between OSEM and reconstructions decreased by 12.0% for smaller lesions and 3.6% for larger lesions. The mean noise levels registered at 13.3 ± 3.9 for and 5 ± 1.5 for . The relative noise difference between OSEM and amounted to 35.0%.
There was a positive correlation between β values and SNR, contrasting the trends observed in SBR and contrast. For small lesions, β values exceeding 100, and for larger lesions, β values surpassing 200 yielded a higher SNR compared to OSEM. The percentage difference in SNR between OSEM and reconstructions decreased by 57.7% for small lesions and 38.9% for large lesions. Both small and large lesion groups displayed the lowest SBR and contrast values with OSEM, while showed the highest. The mean SBRs for and were 6.9 ± 2.7 and 4.6 ± 2.3 for small lesions, and 10.4 ± 5 and 7.6 ± 4.6 for large lesions, respectively. The contrast of small and large lesions on diminished by 52.6% and 40.3% compared to . A statistically significant variance (p < 0.001) was observed in measured SBR and contrast between OSEM and Q.Clear. The percentage deviations in SBR and contrast between OSEM and reconstructions were − 13.6% and − 12.9% for lesions ⩽10 mm in diameter, and − 4.2% and − 3.4% for lesions > 10 mm in diameter, respectively.
Discussion
This investigation provided both quantitative and qualitative assessments of the Q.Clear reconstruction algorithm, contrasting a range of penalization factors (β value) with the prevalent OSEM + PSF algorithm (dubbed OSEM). Analyses were executed on NEMA phantoms filled with varying LBRs and on patients with rectal cancer administered with an 18F-FDG radiopharmaceutical.
The adeptness of Q.Clear to curb potential noise surges facilitates the pragmatic use of heightened iterations (about 25 in Q.Clear against 4 in OSEM). Q.Clear reconstructions exhibited superior , stemming from an increased iteration count and enhanced convergence. High noise in lower β values compromises image quality despite their precise quantification. Conversely, enhanced lesion visibility and consistent cold background were achieved with larger β values (Fig. 3). The BV for a β value of 300 is 5.8 ± 0.4, closely aligned with the BV of OSEM of 5.4 ± 0.4. The outcomes with NEMA phantom are similar to previous findings using NEMA, oval, and anthropomorphic phantom where a β value of 350 parallels OSEM in noise levels [3]. However, this contrasts subtly with Bjöersdorff et al.'s findings, who noted that OSEM reconstruction exhibited noise levels akin to a β of 550 at 1.5-min frames and β at 2.0-min frames [36].
Comparing OSEM and Q.Clear at matched noise levels (β = 300), Q.Clear-constructed images exhibited quantitative superiority over OSEM. For instance, measurements in a 22 mm sphere at an LBR of 4:1 indicated decreases of 21.7% in Δ, Δ and 5.2% in Δ. Similar trends appeared in our clinical datasets. Caribé et al. substantiated that Q.Clear outperforms OSEM in tumor, , and contrast, even when the noise levels are equivalent [17].
The variation in BV resulting from reconstruction with different β values did not exhibit significant differences across various LBRs. The relative difference of BV demonstrated a difference of < 4.1% between LBRs of 2:1 and 8:1 and 3.9% between LBRs of 4:1 and 8:1. This was associated with an insignificant variation between background concentrations in the three LBR examinations (Fig. 2). Reynes-Llompart et al.'s [37] study, which utilized a NEMA phantom with LBRs 2:1, 4:1, and 8:1, reported a 1–2% variance in BV among three LBRs. However, we identified distinct trends for contrast, CR, and , where this relative difference more pronounced in lower LBRs (p < 0.05). A prior study indicated that, in the case of cold lesions in the phantom, the CNR also rises with an increase in the β value, even if the LBR does not seem to influence it [37].
In Q.Clear, relative differences in , CR and contrast were more significant for smaller lesions, attributed to the incorporation of PSF modeling into this algorithm. % dropped by 155.2, 128.8, and 68.1 for the smallest sphere (10 mm); by 26.8, 15.8, and 10.9 for the mid-sized (22 mm); and by 10.3, 7.5, and 4.8 for the largest sphere (37 mm) when LBRs of 2:1, 4:1, and 8:1 were considered, respectively. Our clinical study mirrored these observations. The escalation in quantitative parameters in for small lesions was at least double that of large lesions (Fig. 6). For instance, the relative difference in SNR, SBR, contrast, and between OSEM and decreased by 57.7%, 13.6%, 12.9%, and 12.0% for small lesions, and by 38.9%, 4.2%, 3.4%, and 3.6% for large lesions.
In our phantom study with an LBR of 8:1, all Q.Clear reconstructions yielded significantly lower LE than OSEM. Thus, increased by 54.5 (p < 0.05, Table 2). Our findings align with those of Elin Lindström. They found that LE was elevated for OSEM compared to β values of 133, 267, 400, and 533 [26].
Both phantom and clinical data indicated that quantitative parameters shifted rapidly as the β value escalated to 300. Nevertheless, minor alterations at high β values were reported. , and dwindled by up to 49.5, 46.8 and 37.1. Furthermore, , and also receded by up to 16.0, 19.3, and 18.7 (Figs. 2, 4). Reynes-Llompart et al. [37] highlighted the relative difference of quantitative parameters in Q.Clear, when using a β value of > 500, plateaued.
Our results demonstrate a greater relative difference in CR and BV when using Q.Clear with a BGO scanner compared to the results of previous studies with an LYSO scanner. At an LBR 4:1, the % in spheres with 10 mm and 22 mm diameters decreased by 128.8 and 15.8, respectively. Teoh's study filled the NEMA phantom with a 4:1 ratio and scanned it using an LYSO scanner. Their findings indicated that the % in sphere with diameters of 10 mm and 22 mm was 100.2 and 8.4, respectively [14]. Our clinical investigation found that Q.Clear reconstruction yields greater improvement in quantitative parameters on BGO scanners compared to other scanners. Lesion , SNR and SBR increased by 18.1%, 52.3%, and 16.9%, respectively, in compared to OSEM. Lindström et al. conducted a clinical study using images obtained by an LSO scanner, showing that , in comparison with OSEM, resulted in 11%, 22%, and 12% increases in , SNR and SBR, respectively[26].
Using a low penalizing parameter might increase noise, potentially leading to false positive enhancement when estimating lesion uptake or mistakenly identifying noise as lesions. Conversely, excessive smoothing in Q.Clear with higher β values could lead to reduced RC and, consequently, incorrect negative interpretations. Based on our phantom study, the optimal β value for small lesions ranges from 200 for LBR 2:1 to 300 for LBR 8:1, improving SUV while maintaining an acceptable noise level. For larger lesions, the optimal β value lies between 400 for LBR 2:1 and 500 for LBR 8:1 to enhance SNR. It is vital to recognize the variability in lesion ratios and the lack of preset lesion sizes within clinical studies. Detecting large lesions with high activity is relatively straightforward while pinpointing smaller lesions with low activity is more challenging. Therefore, if only one reconstruction is performed for diagnosis, a β value of 300 is recommended to achieve the most accurate interpretation of the images.
Numerous factors strongly influence the optimization of the Q.Clear algorithm in PET scanning. One pivotal factor is the application or purpose of the PET scan. Different clinical or research needs might necessitate varying levels of image resolution, noise suppression, or contrast enhancement. Contrast is another important element. Lesions with higher contrast (i.e., the pronounced difference in signal intensity compared to surrounding tissues) may require distinct optimization strategies than those with lower contrast. Images with different noise and varying lesion sizes demand unique optimization. The patient count in our study was below the desired number, and the limited range of lesion sizes constrained our analysis. Larger studies are needed to confirm our findings. Assessing the effects of Body Mass Index (BMI), scan duration, various PET applications, and injected dose on optimizing the β-factor for a broader patient population was not the focus of this investigation.
In conclusion, Q.Clear offers enhanced quantitative measurements while maintaining a noise level comparable to the OSEM algorithm. This results in superior image quality and lesion detection. The Q.Clear optimization depends on both lesion size and LBR. As lesion size and LBR decrease, the optimal β value follows suit. For rectal cancer cases, we suggest using for smaller lesions and for larger ones.
Acknowledgements
We acknowledge support from the Department of Nuclear Medicine at Imam Khomeini Hospital Complex, Tehran, Iran.
Abbreviations
- TOF
Time of flight
- BGO
Bismuth germanium oxide
- LBR
Lesion-to-background ratio
- NEMA
National Electrical Manufacturers Association
- OSEM
Ordered subset expectation maximization
- BSREM
Block sequential regularized expectation maximization
- RC
Recovery coefficient
- CR
Contrast recovery
- SNR
Signal-to-noise ratio
- SUV
Standard uptake value
- SBR
Signal-to-background ratio
Author contributions
FS and PS performed phantom preparation and data collection. YM and SF were clinical advisors and involved in the quality control of clinical data. FS and PS analyzed and interpreted the phantom and patient data. FS was involved in writing—original draft preparation. PG and MA were technical designers of the study and contribute to writing reviews and editing. The final manuscript was read and approved by all authors.
Funding
This study has received funding from the Tehran University of Medical Sciences under Grant No. 98-3-101-45508.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Declarations
Ethics approval and consent to participate
Not applicable: Institutional Review Board approval was not required because we worked with phantoms and also the images of patients we removed their data from the images.
Consent for publication
Not applicable: Written informed consent was not required for this study because we analyzed the images of patients we actually removed their data from the images.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Peyman Sheikhzadeh, Email: sheikhzadeh-p@sina.tums.ac.ir.
Pardis Ghafarian, Email: pardis.ghafarian@sbmu.ac.ir.
References
- 1.Muehllehner G, Karp JS. Positron emission tomography. Phys Med Biol. 2006;51(13):R117. doi: 10.1088/0031-9155/51/13/R08. [DOI] [PubMed] [Google Scholar]
- 2.Zeraatkar N, Ay M, Ghafarian P, Sarkar S, Geramifar P, Rahmim A. Monte Carlo-based evaluation of inter-crystal scatter and penetration in the PET subsystem of three GE Discovery PET/CT scanners. Nucl Instrum Methods Phys Res, Sect A. 2011;659(1):508–514. doi: 10.1016/j.nima.2011.07.049. [DOI] [Google Scholar]
- 3.Asma E et al. Quantitatively accurate image reconstruction for clinical whole-body PET imaging. In: Proceedings of the 2012 Asia Pacific signal and information processing association annual summit and conference. IEEE; 2012. p. 1–9.
- 4.Tong S, Alessio AM, Kinahan PE. Image reconstruction for PET/CT scanners: past achievements and future challenges. Imaging Med. 2010;2(5):529. doi: 10.2217/iim.10.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gong K, Kim K, Cui J, Wu D, Li Q. The evolution of image reconstruction in PET: from filtered back-projection to artificial intelligence. PET Clin. 2021;16(4):533–542. doi: 10.1016/j.cpet.2021.06.004. [DOI] [PubMed] [Google Scholar]
- 6.Protonotarios NE, Fokas AS, Vrachliotis A, Marinakis V, Dikaios N, Kastis GA. Reconstruction of preclinical PET images via chebyshev polynomial approximation of the sinogram. Appl Sci. 2022;12(7):3335. doi: 10.3390/app12073335. [DOI] [Google Scholar]
- 7.Son H-K et al. ROC analysis of ordered subset expectation maximization and filtered back projection technique for FDG-PET in lung cancer. In: 2001 IEEE nuclear science symposium conference record (Cat. No. 01CH37310), vol. 3. IEEE; 2001. p. 1801–5.
- 8.Morey AM, Kadrmas DJ. Effect of varying number of OSEM subsets on PET lesion detectability. J Nucl Med Technol. 2013;41(4):268–273. doi: 10.2967/jnmt.113.131904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tatsumi M, et al. Effects of new Bayesian penalized likelihood reconstruction algorithm on visualization and quantification of upper abdominal malignant tumors in clinical FDG PET/CT examinations. Front Oncol. 2021;11:707023. doi: 10.3389/fonc.2021.707023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ketabi A, Ghafarian P, Mosleh-Shirazi MA, Mahdavi SR, Rahmim A, Ay MR. Impact of image reconstruction methods on quantitative accuracy and variability of FDG-PET volumetric and textural measures in solid tumors. Eur Radiol. 2019;29(4):2146–2156. doi: 10.1007/s00330-018-5754-y. [DOI] [PubMed] [Google Scholar]
- 11.Liu Y, et al. Changes of [18F] FDG-PET/CT quantitative parameters in tumor lesions by the Bayesian penalized-likelihood PET reconstruction algorithm and its influencing factors. BMC Med Imaging. 2021;21(1):1–9. doi: 10.1186/s12880-021-00664-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mikami S, Nakamura F, Nakamura A, Torizuka T. Influence of reconstruction FOV and matrix size on the quantitative accuracy of FDG-PET: comparison between OSEM and Bayesian Penalized likelihood. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2021;77(5):454–462. doi: 10.6009/jjrt.2021_JSRT_77.5.454. [DOI] [PubMed] [Google Scholar]
- 13.Hsu DF, Ilan E, Peterson WT, Uribe J, Lubberink M, Levin CS. Studies of a next-generation silicon-photomultiplier–based time-of-flight PET/CT system. J Nucl Med. 2017;58(9):1511–1518. doi: 10.2967/jnumed.117.189514. [DOI] [PubMed] [Google Scholar]
- 14.Teoh EJ, McGowan DR, Macpherson RE, Bradley KM, Gleeson FV. Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system. J Nucl Med. 2015;56(9):1447–1452. doi: 10.2967/jnumed.115.159301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Asma E, Ahn S, Ross SG, Chen A, Manjeshwar RM. Accurate and consistent lesion quantitation with clinically acceptable penalized likelihood images. In: 2012 IEEE Nuclear science symposium and medical imaging conference record (NSS/MIC). IEEE; 2012. p. 4062–6.
- 16.Miwa K, et al. Impact of γ factor in the penalty function of Bayesian penalized likelihood reconstruction (Q.Clear) to achieve high-resolution PET images. EJNMMI Phys. 2023;10(1):4. doi: 10.1186/s40658-023-00527-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Caribé PR, Koole M, D'Asseler Y, Van den Broeck B, Vandenberghe S. Noise reduction using a Bayesian penalized-likelihood reconstruction algorithm on a time-of-flight PET-CT scanner. EJNMMI Phys. 2019;6(1):1–14. doi: 10.1186/s40658-019-0264-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Du J, Ariño-Estrada G, Bai X, Cherry SR. Performance comparison of dual-ended readout depth-encoding PET detectors based on BGO and LYSO crystals. Phys Med Biol. 2020;65(23):235030. doi: 10.1088/1361-6560/abc365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jha A, Mithun S, Puranik A, et al. Performance characteristic evaluation of a bismuth germanate-based high-sensitivity 5-ring discovery image quality positron emission tomography/computed tomography system as per National Electrical Manufacturers Association NU 2–2012. World J Nucl Med. 2019;18(04):351–360. doi: 10.4103/wjnm.WJNM_72_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sah B-R, et al. Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies. Nucl Med Commun. 2017;38(1):57–66. doi: 10.1097/MNM.0000000000000604. [DOI] [PubMed] [Google Scholar]
- 21.Ahn S, et al. Quantitative comparison of OSEM and penalized likelihood image reconstruction using relative difference penalties for clinical PET. Phys Med Biol. 2015;60(15):5733. doi: 10.1088/0031-9155/60/15/5733. [DOI] [PubMed] [Google Scholar]
- 22.Lindström E, Lindsjö L, Sundin A, Sörensen J, Lubberink M. Evaluation of block-sequential regularized expectation maximization reconstruction of 68 Ga-DOTATOC, 18 F-fluoride, and 11 C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner. EJNMMI Phys. 2020;7:1–14. doi: 10.1186/s40658-020-00310-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Trägårdh E, et al. Impact of acquisition time and penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm on a Si-photomultiplier-based PET-CT system for 18 F-FDG. EJNMMI Res. 2019;9:1–10. doi: 10.1186/s13550-019-0535-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sadeghi F, Sheikhzadeh P, Kasraie N, et al. Phantom and clinical evaluation of Block Sequential Regularized Expectation Maximization (BSREM) reconstruction algorithm in 68Ga-PSMA PET-CT studies. Phys Eng Sci Med. 2023;46:1297–1308. doi: 10.1007/s13246-023-01299-4. [DOI] [PubMed] [Google Scholar]
- 25.Chen W, Liang Y. Impact of BSREM reconstruction algorithm on image quality and quantification accuracy of PET-a phantom study. Soc Nucl Med. 2021.
- 26.Lindström E, et al. Evaluation of penalized-likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations. J Nucl Med. 2018;59(7):1152–1158. doi: 10.2967/jnumed.117.200790. [DOI] [PubMed] [Google Scholar]
- 27.Shkumat NA, Vali R, Shammas A. Clinical evaluation of reconstruction and acquisition time for pediatric 18 F-FDG brain PET using digital PET/CT. Pediatr Radiol. 2020;50:966–972. doi: 10.1007/s00247-020-04640-1. [DOI] [PubMed] [Google Scholar]
- 28.Reynés-Llompart G, Gámez-Cenzano C, Romero-Zayas I, Rodríguez-Bel L, Vercher-Conejero JL, Martí-Climent JM. Performance characteristics of the whole-body discovery IQ PET/CT system. J Nucl Med. 2017;58(7):1155–1161. doi: 10.2967/jnumed.116.185561. [DOI] [PubMed] [Google Scholar]
- 29.Daube-Witherspoon ME, Karp JS, Casey ME, et al. PET performance measurements using the NEMA NU 2–2001 standard. J Nucl Med. 2002;43(10):1398–1409. [PubMed] [Google Scholar]
- 30.Monsef A, Ay MR, Sheikhzadeh P, Geramifar P, Rahmim A, Ghafarian P. Harmonization based on quantitative analysis of standardized uptake value variations across PET/CT scanners: a multicenter phantom study. Nucl Med Commun. 2022;43(9):1004–1014. doi: 10.1097/MNM.0000000000001598. [DOI] [PubMed] [Google Scholar]
- 31.Ter Voert EE, Muehlematter UJ, Delso G, et al. Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68 Ga-PSMA PET/MR. EJNMMI Res. 2018;8:1–15. doi: 10.1186/s13550-018-0414-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Devriese J, Beels L, Maes A, Van de Wiele C, Pottel H. Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria. EJNMMI Phys. 2018;5(1):1–13. doi: 10.1186/s40658-018-0235-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Yan J, Schaefferkoetter J, Conti M, Townsend D. A method to assess image quality for low-dose PET: analysis of SNR, CNR, bias and image noise. Cancer Imaging. 2016;16(1):1–12. doi: 10.1186/s40644-016-0086-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Fukukita H, et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0. Ann Nucl Med. 2014;28(7):693–705. doi: 10.1007/s12149-014-0849-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Rouder JN, Morey RD, Speckman PL, Province JM. Default Bayes factors for ANOVA designs. J Math Psychol. 2012;56(5):356–374. doi: 10.1016/j.jmp.2012.08.001. [DOI] [Google Scholar]
- 36.Bjöersdorff M, Oddstig J, Karindotter-Borgendahl N, et al. Impact of penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm for 18 F-fluorocholine PET-CT regarding image quality and interpretation. EJNMMI Phys. 2019;6:1–13. doi: 10.1186/s40658-019-0242-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Reynés-Llompart G, Gámez-Cenzano C, Vercher-Conejero JL, Sabaté-Llobera A, Calvo-Malvar N, Martí-Climent JM. Phantom, clinical, and texture indices evaluation and optimization of a penalized-likelihood image reconstruction method (Q.Clear) on a BGO PET/CT scanner. Med Phys. 2018;45(7):3214–3222. doi: 10.1002/mp.12986. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.